Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3286128 | Clinics and Research in Hepatology and Gastroenterology | 2016 | 5 Pages |
Abstract
SummaryMénétrier's disease is a rare hypertrophic gastropathy, causing protein leak. An overexpression of transforming growth factor alpha is involved. In inhibiting the epidermal growth factor receptor, cetuximab and somatostatin analogues are the two most promising treatments, allowing to avoid radical gastrectomy. We report the case of a patient with a sustained clinical remission after treatment with lanreotide, but without complete endoscopic healing. We discuss the available therapeutic options and present a literature review of somatostatin analogues for the treatment of Ménétrier's disease.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Alexandra Heurgué-Berlot, Thomas Féron, Jean-François Jazeron, Christine Hoeffel, Marie-Danièle Diebold, Guillaume Cadiot,